JP2024017078A - Muscle water content improving agent - Google Patents

Muscle water content improving agent Download PDF

Info

Publication number
JP2024017078A
JP2024017078A JP2022119477A JP2022119477A JP2024017078A JP 2024017078 A JP2024017078 A JP 2024017078A JP 2022119477 A JP2022119477 A JP 2022119477A JP 2022119477 A JP2022119477 A JP 2022119477A JP 2024017078 A JP2024017078 A JP 2024017078A
Authority
JP
Japan
Prior art keywords
water content
extract
muscle
improving agent
muscle water
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022119477A
Other languages
Japanese (ja)
Inventor
朋子 山口
Tomoko Yamaguchi
晴香 松村
Haruka Matsumura
統星 橋本
Subaru Hashimoto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kobayashi Pharmaceutical Co Ltd
Original Assignee
Kobayashi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kobayashi Pharmaceutical Co Ltd filed Critical Kobayashi Pharmaceutical Co Ltd
Priority to JP2022119477A priority Critical patent/JP2024017078A/en
Publication of JP2024017078A publication Critical patent/JP2024017078A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

PROBLEM TO BE SOLVED: To provide an agent that can improve muscle water content.
SOLUTION: Boi-ogi-to extract can increase muscle water content and is therefore suitable as a muscle water content improving agent.
SELECTED DRAWING: None
COPYRIGHT: (C)2024,JPO&INPIT

Description

本発明は、筋肉水分量改善剤に関する。 The present invention relates to an agent for improving muscle water content.

体全体の水分は、その43.4%が筋肉に存在しており、筋肉組織には76%もの水分が含まれている(非特許文献1)。 43.4% of the water in the entire body is present in muscles, and muscle tissue contains as much as 76% water (Non-Patent Document 1).

筋肉量の減少又は筋肉の水分量の減少により体内の水分量が変動すると、生体反応に様々な悪影響を及ぼす。そのような例として、熱中症(非特許文献2)、運動時の持久力パフォーマンス及びスプリントパフォーマンスの低下(非特許文献3)、脳梗塞・心筋梗塞・低血圧症状・免疫不良など(非特許文献4)が挙げられる。 Fluctuations in the amount of water in the body due to a decrease in muscle mass or water content in the muscles have various adverse effects on biological reactions. Such examples include heat stroke (Non-patent Document 2), decreased endurance performance and sprint performance during exercise (Non-patent Document 3), cerebral infarction, myocardial infarction, hypotension symptoms, immunodeficiency, etc. (Non-patent Document 3), etc. 4).

空気調和・衛生工学 1979 53 (7) p.617-622Air conditioning and sanitary engineering 1979 53 (7) p.617-622 熱中症環境保健マニュアル2008、環境省Heatstroke Environmental Health Manual 2008, Ministry of the Environment 競技者のための暑熱対策ガイドブック、平成29年、独立行政法人日本スポーツ振興センター、国立スポーツ科学センターHeat countermeasure guidebook for athletes, 2017, Japan Sports Promotion Center, National Sports Science Center “人間の体は60~70%が水分と言われていますが、最も多く水分を含んでいるのは身体のどこ?”,[online],2017年10月31日,保険診療所 横浜ベイ・ライフサービス株式会社,[令和4年7月22日検索],インターネット<URL:https://www.hoken119.co.jp/info/qa/%E4%BA%BA%E9%96%93%E3%81%AE%E4%BD%93%E3%81%AF60%EF%BD%9E70%EF%BC%85%E3%81%8C%E6%B0%B4%E5%88%86%E3%81%A8%E8%A8%80%E3%82%8F%E3%82%8C%E3%81%A6%E3%81%84%E3%81%BE%E3%81%99%E3%81%8C%E3%80%81%E6%9C%80/>“It is said that the human body is 60-70% water, but where in the body does it contain the most water?”, [online], October 31, 2017, Insurance Clinic Yokohama Bay Life Service Co., Ltd., [searched on July 22, 2020], Internet <URL: https://www.hoken119.co.jp/info/qa/%E4%BA%BA%E9%96%93%E3% 81%AE%E4%BD%93%E3%81%AF60%EF%BD%9E70%EF%BC%85%E3%81%8C%E6%B0%B4%E5%88%86%E3%81% A8%E8%A8%80%E3%82%8F%E3%82%8C%E3%81%A6%E3%81%84%E3%81%BE%E3%81%99%E3%81%8C% E3%80%81%E6%9C%80/>

体内の水分量を上げるためには、水分の貯蔵庫である筋肉の量を増やすことが早道といえる。しかしながら、筋肉の量を増やすことは容易ではなく、特に、女性や高齢者は筋肉量が低下する傾向にあるため、その難易度は一層高くなる。もし、筋肉中の水分量を増やすことができれば、筋肉量が少ない人であっても、筋肉量を増やすことに相当する体内水分量の改善が期待できる。 The quickest way to increase the amount of water in your body is to increase the amount of muscle that stores water. However, it is not easy to increase muscle mass, and it is especially difficult for women and the elderly because their muscle mass tends to decrease. If we can increase the amount of water in our muscles, even people with little muscle mass can expect to improve their body water content, which is equivalent to increasing muscle mass.

そこで本発明は、筋肉水分量を改善できる薬剤を提供することを目的とする。 Therefore, an object of the present invention is to provide a drug that can improve muscle water content.

本発明者は鋭意検討の結果、防已黄耆湯エキスに筋肉水分量を改善できる作用があることを見出した。本発明は、この知見に基づいて、更に検討を重ねることにより完成したものである。 As a result of intensive studies, the inventors of the present invention have discovered that Hobakokito extract has the effect of improving muscle water content. The present invention was completed through further studies based on this knowledge.

即ち、本発明は、下記に掲げる態様の発明を提供する。
項1. 防已黄耆湯エキスを含む、筋肉水分量改善剤。
項2. 更年期以降の女性に対して適用される、項1に記載の筋肉水分量改善剤。
That is, the present invention provides the inventions of the following aspects.
Item 1. A muscle water content improving agent containing Hokiokito extract.
Item 2. Item 1. The muscle water content improving agent according to item 1, which is applied to women after menopause.

本発明によれば、筋肉水分量を改善できる薬剤が提供される。 According to the present invention, a drug capable of improving muscle water content is provided.

防已黄耆湯エキスによる筋肉水分量改善効果を示す。Demonstrates the effect of Hokiokito extract on improving muscle water content.

本発明は、防已黄耆湯エキスを含み、筋肉水分量改善剤として用いられることを特徴とする。以下、本発明の筋肉水分量改善剤について詳述する。 The present invention is characterized in that it contains Bokkito extract and is used as a muscle water content improving agent. Hereinafter, the muscle water content improving agent of the present invention will be explained in detail.

有効成分
防已黄耆湯としては、「新 一般用漢方処方の手引き」(合田 幸広・袴塚 高志監修、日本漢方生薬製剤協会編集、株式会社じほう発行)に記載されている漢方処方が好ましく、ボウイ、オウギ、ジュツ(ビャクジュツ及びソウジュツが挙げられ、好ましくはビャクジュツが挙げられる。)、ショウキョウ、タイソウ、カンゾウからなる混合生薬が挙げられる。また、防已黄耆湯には、漢方生薬調査会により定められた「漢方製剤の基本的取扱い方針」に規定されるように、現在繁用されている漢方関係の書簡に記載されている混合生薬(漢方処方)が包含される。
As for the active ingredient Hobaokito, it is preferable to use the Chinese herbal prescriptions listed in the "New General Chinese Herbal Prescription Guide" (supervised by Yukihiro Goda and Takashi Hakamazuka, edited by the Japan Traditional Chinese Herbal Medicine Preparation Association, published by Jiho Co., Ltd.). Examples include mixed herbal medicines consisting of , Aspergillus japonica , Jutsu (includes Sandalwood jutsu and Sojutsu , preferably Sandalwood jutsu is mentioned), Gingerbread, Astragalus, and Licorice. In addition, Bokiokito contains the mixtures listed in the letters related to herbal medicines that are currently frequently used, as stipulated in the "Basic Handling Policy for Chinese Herbal Preparations" established by the Kampo Herbal Medicine Investigation Committee. Includes crude drugs (Chinese herbal prescriptions).

本発明における防已黄耆湯エキスは、上記の混合生薬を抽出処理し、得られた抽出液を必要に応じて濃縮することでエキス液として得てもよいし、エキス液を乾燥処理することでエキス末として得てもよい。 The Bokiokito extract in the present invention may be obtained as an extract liquid by extracting the above-mentioned mixed herbal medicine and concentrating the obtained extract liquid as necessary, or by drying the extract liquid. It can also be obtained as an extract powder.

防已黄耆湯エキスの製造において、抽出処理に使用される抽出溶媒としては、特に限定されないものの、一例として水又は含水エタノールが挙げられる。また、乾燥処理としても、特に限定されず、公知の方法、例えば、スプレードライ法や、エキス液の濃度を高めた軟エキスに対して適当な吸着剤(例えば無水ケイ酸、デンプン等)を加えて吸着末とする方法等が挙げられる。 In the production of Hoba Okito extract, the extraction solvent used in the extraction process is not particularly limited, but water or aqueous ethanol can be mentioned as an example. The drying process is not particularly limited, and may be performed using a known method such as spray drying, or by adding an appropriate adsorbent (for example, silicic anhydride, starch, etc.) to a soft extract with increased concentration of the extract liquid. Examples include a method of making an adsorbed powder.

本発明において用いられる防已黄耆湯エキスとしては、前述の方法で調製したエキスを使用してもよいし、市販されるものを使用してもよい。例えば、防已黄耆湯のエキス末としては、防已黄耆湯乾燥エキスAおよび防已黄耆湯乾燥エキスAZ(いずれも日本粉末株式会社製)、並びに防已黄耆湯エキス末および防已黄耆湯乾燥エキス-F(いずれもアルプス薬品工業株式会社製)等がそれぞれ商品として知られており、商業的に入手することもできる。 As the Bokkito extract used in the present invention, an extract prepared by the method described above may be used, or a commercially available extract may be used. For example, as the extract powder of Hoki-o-kito, Bo-ki-o-ki-to dry extract A and Hoki-oki-to dry extract AZ (both manufactured by Nippon Powder Co., Ltd.), Boki-oki-to extract powder and Hoki-oki-to dry extract AZ are available. Bōkito Dry Extract-F (all manufactured by Alps Yakuhin Kogyo Co., Ltd.) and the like are known as commercial products and can also be obtained commercially.

本発明の筋肉水分量改善剤において、防已黄耆湯エキスの含有量としては、本発明の効果を奏する限り特に限定されないが、乾燥エキス量換算で、例えば1~100重量%が挙げられる。乾燥エキス量換算とは、乾燥エキス(エキス末)を使用する場合にはそれ自体の量でありエキス液や軟エキスを使用する場合には、溶媒を除去した残量に換算した量である。また、乾燥エキス末が、製造時に添加される吸着剤等の添加剤を含む場合は、当該添加剤を除いた量である。 In the muscle water content improving agent of the present invention, the content of the Hobaokito extract is not particularly limited as long as the effects of the present invention are achieved, but examples include, for example, 1 to 100% by weight in terms of dry extract amount. The term "converted amount of dry extract" refers to the amount itself when using a dry extract (extract powder), and when using an extract liquid or soft extract, it refers to the amount converted to the remaining amount after removing the solvent. Moreover, when the dry extract powder contains additives such as adsorbents added during production, the amount is the amount excluding the additives.

他の含有成分
本発明の筋肉水分量改善剤は、防已黄耆湯エキス単独からなるものであってもよく、製剤形態に応じた添加剤や基剤を含んでいてもよい。このような添加剤及び基剤としては、薬学的に許容されることを限度として特に制限されないが、例えば、賦形剤、結合剤、崩壊剤、滑沢剤、等張化剤、可塑剤、分散剤、乳化剤、溶解補助剤、湿潤化剤、安定化剤、懸濁化剤、粘着剤、コーティング剤、光沢化剤、水、油脂類、ロウ類、炭化水素類、脂肪酸類、高級アルコール類、エステル類、水溶性高分子、界面活性剤、金属石鹸、低級アルコール類、多価アルコール、pH調整剤、緩衝剤、酸化防止剤、紫外線防止剤、防腐剤、矯味剤、香料、粉体、増粘剤、色素、キレート剤等が挙げられる。これらの添加剤は、1種単独で使用してもよく、また2種以上を組み合わせて使用してもよい。また、これらの添加剤及び基剤の含有量については、使用する添加剤及び基剤の種類、筋肉水分量改善剤の製剤形態等に応じて適宜設定される。
Other Ingredients The muscle water content improving agent of the present invention may consist of the Hobakokito extract alone, or may contain additives and bases depending on the formulation form. Such additives and bases are not particularly limited as long as they are pharmaceutically acceptable, but include, for example, excipients, binders, disintegrants, lubricants, tonicity agents, plasticizers, Dispersants, emulsifiers, solubilizing agents, wetting agents, stabilizers, suspending agents, adhesives, coating agents, brightening agents, water, oils and fats, waxes, hydrocarbons, fatty acids, higher alcohols , esters, water-soluble polymers, surfactants, metal soaps, lower alcohols, polyhydric alcohols, pH adjusters, buffers, antioxidants, ultraviolet inhibitors, preservatives, flavorings, fragrances, powders, Examples include thickeners, dyes, chelating agents, and the like. These additives may be used alone or in combination of two or more. Further, the contents of these additives and bases are appropriately set depending on the types of additives and bases used, the formulation form of the muscle water content improving agent, and the like.

本発明の筋肉水分量改善剤は、防已黄耆湯エキスの他に、必要に応じて、他の薬理成分を含んでいてもよい。このような薬理成分の種類については、特に限定されないが、例えば、制酸剤、健胃剤、消化剤、整腸剤、鎮痙剤、粘膜修復剤、抗炎症剤、収れん剤、鎮吐剤、鎮咳剤、去痰剤、消炎酵素剤、鎮静催眠剤、抗ヒスタミン剤、カフェイン類、強心利尿剤、抗菌剤、血管収縮剤、血管拡張剤、局所麻酔剤、生薬、生薬エキス末、ビタミン類、メントール類等が挙げられる。これらの薬理成分は、1種単独で使用してもよく、また2種以上を組み合わせて使用してもよい。また、これらの薬理成分の含有量については、使用する薬理成分の種類等に応じて公知のものから適宜設定すればよい。 The muscle water content improving agent of the present invention may contain other pharmacological ingredients in addition to the Hobaokito extract, if necessary. The types of such pharmacological ingredients are not particularly limited, but include, for example, antacids, stomachic agents, digestive agents, intestinal regulators, antispasmodics, mucosal repair agents, anti-inflammatory agents, astringents, antiemetics, antitussives, expectorants, and anti-inflammatory agents. Enzymes, sedative-hypnotics, antihistamines, caffeine, cardiotonic diuretics, antibacterial agents, vasoconstrictors, vasodilators, local anesthetics, herbal medicines, herbal extract powders, vitamins, menthol, etc. These pharmacological ingredients may be used alone or in combination of two or more. Moreover, the content of these pharmacological components may be appropriately set from known ones depending on the type of pharmacological components to be used.

製剤形態
本発明の筋肉水分量改善剤の製剤形態については、経口投与が可能であることを限度として特に制限されないが、例えば、散剤、細粒剤、顆粒剤(ドライシロップを含む)、錠剤、丸剤、カプセル剤(軟カプセル剤、硬カプセル剤)等の固形状製剤;ゼリー剤等の半固形状製剤;液剤、懸濁剤、シロップ剤等の液状製剤が挙げられる。これらの製剤形態の中でも、含有成分の安定性や携帯性等の観点から、好ましくは固形状製剤が挙げられる。
Formulation Form The form of formulation of the muscle water content improving agent of the present invention is not particularly limited as long as it can be administered orally, but examples include powders, fine granules, granules (including dry syrup), tablets, and pills. Examples include solid preparations such as tablets and capsules (soft capsules and hard capsules); semi-solid preparations such as jellies; and liquid preparations such as solutions, suspensions, and syrups. Among these formulation forms, solid formulations are preferred from the viewpoints of stability of contained ingredients, portability, and the like.

本発明の筋肉水分量改善剤を前記製剤形態に調製するには、防已黄耆湯エキス、並びに必要に応じて添加される添加剤、基剤、及び薬理成分を用いて、医薬分野で採用されている通常の製剤化手法に従って製剤化すればよい。 In order to prepare the muscle water content improving agent of the present invention into the above-mentioned formulation form, Bokiokito extract and additives, bases, and pharmacological ingredients added as necessary are used in the pharmaceutical field. It may be formulated according to the conventional formulation method.

用途
本発明の筋肉水分量改善剤は、筋肉水分量の改善の目的で用いられることを限度として、任意の用途に用いることができる。筋肉水分量の改善とは、低下した筋肉水分量を、正常量又は正常量を超える量に増大させることをいう。より具体的には、本発明の筋肉水分量改善剤は、筋肉水分量の改善作用を利用して、筋肉量の低下に伴う水分量の低下又は筋肉水分量の低下に基づく症状の、抑制又は改善の目的で用いることができる。さらに具体的には、本発明の筋肉水分量改善剤は、熱中症の予防又は改善、運動時の持久力パフォーマンス又はスプリントパフォーマンスの低下の予防又は改善、脳梗塞、心筋梗塞、低血圧症状、免疫不良等の健康障害の予防又は改善等が挙げられる。
Applications The muscle water content improving agent of the present invention can be used for any purpose as long as it is used for the purpose of improving muscle water content. Improving muscle water content refers to increasing the reduced muscle water content to a normal amount or an amount exceeding the normal amount. More specifically, the muscle water content improving agent of the present invention utilizes the muscle water content improving effect to suppress or suppress a decrease in water content associated with a decrease in muscle mass or symptoms based on a decrease in muscle water content. It can be used for improvement purposes. More specifically, the muscle water content improving agent of the present invention can prevent or improve heatstroke, prevent or improve endurance performance during exercise or decrease in sprint performance, cerebral infarction, myocardial infarction, hypotension symptoms, immunity. Examples include prevention or improvement of health disorders such as poor health.

本発明の筋肉水分量改善剤は、筋肉水分量を増大させる作用があることから、水分貯蔵庫である筋肉量が少ない対象に適用されることが好ましい。このような対象としては、運動不足を自覚している人、女性、高齢者等が挙げられ、中でも好ましくは、更年期以降の女性が挙げられる。 Since the muscle water content improving agent of the present invention has the effect of increasing muscle water content, it is preferably applied to subjects with a small amount of muscle, which is a water storage reservoir. Such subjects include people who are aware of lack of exercise, women, elderly people, etc. Among them, women who are after menopause are preferred.

用量・用法
本発明の筋肉水分量改善剤は、経口投与によって投与される。本発明の筋肉水分量改善剤の投与量については、対象となる症状及び年齢等に応じて適宜設定される。例えば、1日当たりの摂取量として、防已黄耆湯エキスの乾燥エキス量換算量で、1300~6000mg、好ましくは2000~4800mg、より好ましくは3000~4000mgが挙げられる。
Dose/Administration The muscle water content improving agent of the present invention is administered orally. The dosage of the muscle water content improving agent of the present invention is appropriately determined depending on the symptoms, age, etc. of the subject. For example, the daily intake amount of Hoba Okito extract in terms of dry extract amount is 1,300 to 6,000 mg, preferably 2,000 to 4,800 mg, and more preferably 3,000 to 4,000 mg.

本発明の筋肉水分量改善剤の服用タイミングについては特に制限されず、食前、食後、又は食間のいずれであってもよいが、好ましくは食前又は食間が挙げられる。 The timing of taking the muscle water content improving agent of the present invention is not particularly limited, and may be taken before meals, after meals, or between meals, but preferably before meals or between meals.

以下、本発明を実施例により具体的に説明するが、本発明はこれらの実施例に限定されるものではない。 EXAMPLES Hereinafter, the present invention will be specifically explained with reference to Examples, but the present invention is not limited to these Examples.

防已黄耆湯(BOT)エキス末の調製
原料生薬として、ショウキョウ1(重量部、以下同じ)、タイソウ3、ボウイ5、ビャクジュツ3、オウギ5、カンゾウ1.5の割合で用い、これらを刻んだ後、水20倍重量を用いて約100℃で1時間抽出し、遠心分離して抽出液を得、減圧下で濃縮してスプレードライヤーを用いて乾燥し、防已黄耆湯エキス末を得た。なお、スプレードライヤーによる乾燥は、抽出液を回転数10000rpmのアトマイザーに落下させ、150℃の空気の熱風を供給して行った。
As a raw material crude drug for the preparation of BOT extract powder , 1 part by weight of ginger, 3 parts by weight, 5 parts by weight, 3 parts byakujutsu, 5 parts by weight, and 1.5 parts by weight of licorice were used. After chopping, it was extracted at about 100°C for 1 hour using 20 times the weight of water, centrifuged to obtain an extract, concentrated under reduced pressure, and dried using a spray dryer to obtain Boba Okeito extract powder. I got it. Note that drying with a spray dryer was performed by dropping the extract into an atomizer with a rotational speed of 10,000 rpm, and supplying hot air at 150°C.

実験方法
雌性C57BL/6Jマウスを用い、6週齢時に、2つの卵巣摘出群(OVX)と1つの偽手術群(Sham)とを作製し、普通食を給餌して2週間の回復期間を経た後、さらに2週間、高脂肪食を給餌した。なお、2つのOVX群のうち一方(これをOVX-BOT群とする。)に給餌する高脂肪食には、2重量%の防已黄耆湯(BOT)エキス末を配合した。
Experimental method Using female C57BL/6J mice, two ovariectomized groups (OVX) and one sham-operated group (Sham) were created at the age of 6 weeks, and they were fed normal food and underwent a 2-week recovery period. Afterwards, they were fed a high-fat diet for an additional two weeks. The high-fat diet fed to one of the two OVX groups (this will be referred to as the OVX-BOT group) contained 2% by weight of Bobaokito (BOT) extract powder.

その後、ふくらはぎの筋肉を摘出し、その重量(湿重量)を測定した。さらに、摘出したふくらはぎの筋肉を凍結乾燥させ、恒量になるまで乾燥させた。乾燥後、再度重量(乾燥重量)を測定し、湿重量から乾燥重を差し引いて得られる水分量の、乾燥重量に対する比率(%)を、筋肉水分量として導出した。結果を図1に示す。 Thereafter, the calf muscle was extracted and its weight (wet weight) was measured. Furthermore, the extracted calf muscles were freeze-dried and dried until they reached a constant weight. After drying, the weight (dry weight) was measured again, and the ratio (%) of the water content to the dry weight obtained by subtracting the dry weight from the wet weight was derived as the muscle water content. The results are shown in Figure 1.

結果
図1に示す通り、OVX-BOT群では、筋肉水分量が顕著に増大したことが認められた。つまり、防已黄耆湯エキスに、優れた筋肉水分量の改善効果があることが認められた。
Results As shown in Figure 1, it was observed that muscle water content significantly increased in the OVX-BOT group. In other words, it was confirmed that Hobakokito extract has an excellent effect on improving muscle water content.

Claims (2)

防已黄耆湯エキスを含む、筋肉水分量改善剤。 A muscle water content improving agent containing Hokiokito extract. 更年期以降の女性に対して適用される、請求項1に記載の筋肉水分量改善剤。 The muscle water content improving agent according to claim 1, which is applied to women after menopause.
JP2022119477A 2022-07-27 2022-07-27 Muscle water content improving agent Pending JP2024017078A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2022119477A JP2024017078A (en) 2022-07-27 2022-07-27 Muscle water content improving agent

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2022119477A JP2024017078A (en) 2022-07-27 2022-07-27 Muscle water content improving agent

Publications (1)

Publication Number Publication Date
JP2024017078A true JP2024017078A (en) 2024-02-08

Family

ID=89807055

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022119477A Pending JP2024017078A (en) 2022-07-27 2022-07-27 Muscle water content improving agent

Country Status (1)

Country Link
JP (1) JP2024017078A (en)

Similar Documents

Publication Publication Date Title
CN111588816A (en) Medicine composition for clearing lung-heat chemical fibers and application thereof
WO2019183028A1 (en) Nutritional product and method of using it
JP2024017078A (en) Muscle water content improving agent
JP6935285B2 (en) Pharmaceutical composition
JP7068803B2 (en) Pharmaceutical composition for reducing blood lipids
JP2020114807A (en) Estrogen increasing agent
CN104337898B (en) A kind of Chinese medicine composition of the treatment gout containing Semen Pruni
JP6938315B2 (en) tablet
JP7385990B2 (en) Hypersomnia treatment
JP2024017060A (en) Tie2 activator
JP2022098251A (en) Premenstrual constipation improver
JP2023145935A (en) Takusyato extract preparation
JP2024028682A (en) Fibrosis inhibitor
JP2024031740A (en) Medication for improving evening sickness
JP2022094421A (en) Liver function improver
US10933109B2 (en) Compositions and methods for sleep disorders and restless leg syndromes
JP2022000423A (en) Fat in feces discharge promoter
JP2024015395A (en) Hydragogue agent
JP2022011233A (en) Agent for improving fatigue of lower limbs
JP2023067056A (en) Hypogastric fat reducer
JP2024029735A (en) Crowd disorder improvement medicine
JP2021167309A (en) Fat reducer
JP2021161041A (en) Heart frequency increment inhibitor for inhibiting increment of heart frequency in drinking
JP2022118264A (en) Lipid eliminant
JP2024034027A (en) Chinese herbal extract preparation